By Ifham Nizam
The mosquito that spreads dengue is tiny. The financial burden it leaves behind is anything but.
As Sri Lanka grapples with its worst dengue outbreak in nearly a decade, the country’s free public healthcare system is absorbing a mounting financial shock that experts say could run into billions of rupees, even as the human toll continues to rise.
According to the National Dengue Control Unit (NDCU), more than 76,000 dengue infections and 53 deaths have been reported so far this year, making 2026 one of the most challenging years for dengue control in recent history.
The NDCU has warned that the outbreak is being driven largely by the highly virulent DENV-2 strain, while persistent rainfall, poor waste management and mosquito breeding in urban and semi-urban areas continue to fuel transmission.
Although the Ministry of Health has yet to publish an official estimate of the cost of treating dengue patients, the economic implications are becoming increasingly evident.
Published medical research estimates that treating a dengue patient costs between USD 239 and USD 1,056, depending on the severity of the illness. At an exchange rate of around Rs. 330 to the US dollar, this translates to approximately Rs. 79,000 to Rs. 348,000 per patient.
Applied to the more than 76,000 reported cases, the theoretical direct medical cost ranges from Rs. 6 billion to more than Rs. 26 billion. While many patients are treated as outpatients and therefore incur lower costs, the estimates underline the immense financial pressure being placed on Sri Lanka’s publicly funded healthcare system.
The National Dengue Control Unit has repeatedly urged the public to eliminate mosquito breeding sites, warning that hospitals alone cannot contain the outbreak without sustained community participation.
Health officials have intensified countrywide inspections, awareness campaigns and vector-control programmes as case numbers continue to climb.
Officials say hospitals have expanded dengue wards, increased bed capacity and deployed additional medical and nursing staff to cope with the surge in admissions.
The government has also mobilised Air Force drones to identify inaccessible mosquito breeding grounds while strengthening surveillance operations across high-risk districts.
The financial impact extends beyond the Ministry of Health. Families lose income when wage earners fall ill or parents stay home to care for infected children. Businesses suffer productivity losses, while schools experience increased absenteeism during peak transmission periods.
Sri Lanka’s previous major dengue epidemic in 2017 was estimated to have cost around Rs. 1.94 billion in healthcare and outbreak-control expenditure. With inflation, higher pharmaceutical prices and increased operational costs since then, health economists believe the financial burden of the current outbreak is likely to be substantially greater.
The outbreak also raises broader questions about climate resilience and public investment. Dengue is increasingly being recognised not merely as a seasonal health issue but as an economic challenge capable of straining government finances and slowing productivity.
For the National Dengue Control Unit, the message remains simple: prevention is far cheaper than treatment.
Every breeding site destroyed, every community clean-up campaign conducted and every household inspection completed reduces the need for costly hospital care.
As the monsoon continues to create favourable conditions for mosquito breeding, the NDCU warns that sustained public vigilance will determine whether the country’s health bill continues to climb—or begins to fall.
from The Island https://ift.tt/4haqMvW
